Literature DB >> 12055104

Differential requirement for NF-kappaB-inducing kinase in the induction of NF-kappaB by IL-1beta, TNF-alpha, and Fas.

Maria P Russo1, Brydon L Bennett, Anthony M Manning, David A Brenner, Christian Jobin.   

Abstract

In this study, we examined the role of the nuclear factor-kappaB (NF-kappaB)-inducing kinase (NIK) in distinct signaling pathways leading to NF-kappaB activation. We show that a dominant-negative form of NIK (dnNIK) delivered by adenoviral (Ad5dnNIK) vector inhibits Fas-induced IkappaBalpha phosphorylation and NF-kappaB-dependent gene expression in HT-29 and HeLa cells. Interleukin (IL)-1beta- and tumor necrosis factor-alpha (TNF-alpha)-induced NF-kappaB activation and kappaB-dependent gene expression are inhibited in HeLa cells but not in Ad5dnNIK-infected HT-29 cells. Moreover, Ad5dnNIK failed to sensitize HT-29 cells to TNF-alpha-induced apoptosis at an early time point. However, cytokine- and Fas-induced signals to NF-kappaB are finally integrated by the IkappaB kinase (IKK) complex, since IkappaBalpha phosphorylation, NF-kappaB DNA binding activity, and IL-8 gene expression were strongly inhibited in HT-29 and HeLa cells overexpressing dominant-negative IKKbeta (Ad5dnIKKbeta). Our findings support the concept that cytokine signaling to NF-kappaB is redundant at the level of NIK. In addition, this study demonstrates for the first time the critical role of NIK and IKKbeta in Fas-induced NF-kappaB signaling cascade.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055104     DOI: 10.1152/ajpcell.00166.2001

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  8 in total

1.  Tumor necrosis factor (TNF)-alpha-induced IL-8 expression in gastric epithelial cells: role of reactive oxygen species and AP endonuclease-1/redox factor (Ref)-1.

Authors:  Ann M O'Hara; Asima Bhattacharyya; Jie Bai; Randy C Mifflin; Peter B Ernst; Sankar Mitra; Sheila E Crowe
Journal:  Cytokine       Date:  2009-04-18       Impact factor: 3.861

2.  Fas pulls the trigger on psoriasis.

Authors:  Amos Gilhar; Ron Yaniv; Bedia Assy; Sima Serafimovich; Yehuda Ullmann; Richard S Kalish
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

3.  Regulation and functional impact of lipopolysaccharide induced Nod2 gene expression in the murine epididymal epithelial cell line PC1.

Authors:  Marcus Mühlbauer; Adam W Cheely; Suresh Yenugu; Christian Jobin
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

4.  Constitutive nuclear factor-kappa B activity is required for central neuron survival.

Authors:  Asha L Bhakar; Laura-Lee Tannis; Christine Zeindler; Maria Pia Russo; Christian Jobin; David S Park; Sandra MacPherson; Philip A Barker
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

5.  Cystic fibrosis transmembrane conductance regulator controls lung proteasomal degradation and nuclear factor-kappaB activity in conditions of oxidative stress.

Authors:  Emilie Boncoeur; Telma Roque; Elise Bonvin; Vinciane Saint-Criq; Monique Bonora; Annick Clement; Olivier Tabary; Alexandra Henrion-Caude; Jacky Jacquot
Journal:  Am J Pathol       Date:  2008-03-27       Impact factor: 4.307

Review 6.  Life in the Fas lane: differential outcomes of Fas signaling.

Authors:  Elizabeth Brint; Grace O'Callaghan; Aileen Houston
Journal:  Cell Mol Life Sci       Date:  2013-04-12       Impact factor: 9.261

7.  Functional Crosstalk between PCSK9 Internalization and Pro-Inflammatory Activation in Human Macrophages: Role of Reactive Oxygen Species Release.

Authors:  Rafael I Jaén; Adrián Povo-Retana; César Rosales-Mendoza; Patricia Capillas-Herrero; Sergio Sánchez-García; Paloma Martín-Sanz; Marina Mojena; Patricia Prieto; Lisardo Boscá
Journal:  Int J Mol Sci       Date:  2022-08-14       Impact factor: 6.208

8.  Regulation of TAK1/TAB1-mediated IL-1β signaling by cytoplasmic PPARβ/δ.

Authors:  Josefine Stockert; Alexander Wolf; Kerstin Kaddatz; Evelyn Schnitzer; Florian Finkernagel; Wolfgang Meissner; Sabine Müller-Brüsselbach; Michael Kracht; Rolf Müller
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.